The Kraft Heinz lawsuit against Aetna is the ‘tip of the iceberg’

The latest stories trending on MedCity News.

Editor's Pick

Top Story The Kraft Heinz Lawsuit Against Aetna Is the 'Tip of the Iceberg' Kraft Heinz recently sued Aetna, claiming that the insurer is not providing all of Kraft Heinz's medical claims data. More lawsuits of this sort are likely to come, experts warned. Sponsored Content Take Our Survey! How Do Consultants View The Healthcare Landscape and Employee Benefits? Presented by MedCity News Your experience positions you to be a thought leader so your participation is vital to this research. We will use the data gathered from this survey for a report exploring how the role of the consultant is evolving, in line with the needs of self-insured employers and the shifting healthcare landscape. We value your input.  Click here to take the survey.  If you complete the survey, you will be eligible for a $250 gift card.

Featured News

An AI-Enabled Approach to Improve Access to Physical Therapy for Self-Insured Employers Quantum Health has bolstered its collaboration with Sword Health by integrating MSK services to members to track home exercise, avoid unnecessary surgery and support treatment of pelvic conditions. Advice Given by ChatGPT Vs. Human Providers Is Nearly Indistinguishable, NYU Study Says NYU researchers conducted a study this year in which nearly 400 people were asked to identify whether responses to patient questions were produced by human providers or ChatGPT. Participants had a limited ability to tell the source of the responses apart, so the study authors concluded that the use of LLMs like ChatGPT could be an effective way to streamline healthcare providers' communication with patients. Prominence Health Plan Taps Strive Health for Kidney Care Prominence Health Medicare Advantage enrollees will have 24/7 access to Strive Health's specialized care team through a new partnership. Strive Health is also teaming up with Sierra Nevada Specialty Care, a local nephrology clinic in Nevada. FDA Approval of RSV Drug Gives Infants and Toddlers Long-Lasting Protection AstraZeneca and Sanofi drug Beyfortus is now FDA approved for preventing respiratory problems from RSV infection in infants and toddlers. Antibody engineering enables the drug to last longer in the body, providing protective effects for potentially the entire RSV season. What Misconceptions Does the Healthcare Industry Still Have About Home-Based Care? The at-home care field holds significant market potential. As the subsector continues to grow, some leaders of home healthcare startups are challenging misconceptions that some other industry stakeholders may still have, including the misbelief that at-home care is only for senior citizens and that this care model lacks scalability. Eli Lilly Strengthens the Case for Going Early in Alzheimer's Treatment Alzheimer's disease patients in the earliest stages of their disease benefited the most from Eli Lilly drug donanemab, which is expected to receive an FDA decision by the end of 2023. Full results from the drug's pivotal study were presented during the during the Alzheimer's Association International Conference.

Resources

Sponsored Content AI in Healthcare: Scratching the Surface Learn how AI is transforming the healthcare industry and the pitfalls that also exist with its early adoption. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe